3628 results for «384»
3628 results
ANOCA/INOCA: when angiography is not enough to reach a diagnosis
16 May 2024 – From EuroPCR 2024
This session provides practical knowledge on the diagnosis and management of patients with ANOCA/INOCA (Angina with Non-Obstructive Coronary Arteries/Ischemia with Non-Obstructive Coronary Arteries). It covers the evaluation of microvascular and vasomotor disorders in patients with non-obstructive coronary arteries, and the causes and management of patients with...
PCR's Got Talent - Round 2 - Session 2
15 May 2024 – From EuroPCR 2024
This session features a selected abstract submission from EuroPCR 2024 on plaque characterization, outcomes, and predictors of recurrent events in stent failure, as studied using optical coherence tomography (OCT).
PCR's Got Talent - Round 2 - Session 1
15 May 2024 – From EuroPCR 2024
Disrupt CAD III: Safety and effectiveness of intravascular lithotripsy for treatment of severe coronary calcification
17 Oct 2020
At TCT Connect 2020, Dean Kereiakes presented the results of the Disrupt CAD III trial. Giuseppe Di Gioia and Dejan Milasinovic provide a summary of the key messages.
Author
Author
Surgical left atrial appendage occlusion in VHD without AF: OPINION Trial
03 Sep 2025
Alex Sticchi provides his take on the results of the OPINION trial presented by Yang Wang at the ESC Congress 2025 in Madrid.
Author
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
07 Nov 2022
Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.
This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...
Author
Cardiac biomarkers in patients with asymptomatic severe aortic stenosis: primary biomarker analysis from the EARLY TAVR Trial
01 Apr 2025
Elad Asher provides his take on the primary biomarker analysis from the EARLY TAVR Trial presented by Brian R. Lindman at ACC.25 in Chicago.
Author
Summary and take home messages of the late-breaking clinical trials presented during #TCTConnect 2020
19 Oct 2020
Vijay Kunadian provides a summary of the coronary & structural late-breaking studies presented during TCT Connect 2020 and shares some take-home messages. See how these studies might influence your daily practice!
Author
